Ann: Bell Potter Healthcare Conference Presentation, page-5

Another timeline blowout on page 17 .....

14 months ago the market was advised that there was supposedly some companies that had 'already expressed interest in VivaGel® BV' when Mundipharma got the boot and yet today Cheryl has given herself another 12 months to try and find a new VivaGel® BV for the EU ? Perhaps the 'interest' touted in the 2023 ASX announcement wasn't as strong as Starpharma inferred ?

.... but hey the blind faith group don't seem to have any issues with today's presentation ?








Melbourne, Australia; 14 August 2023: Starpharma (ASX: SPL, OTCQX: SPHRY) today announces it has negotiated a commercial settlement agreement with Mundipharma in relation to the VivaGel® BV product.

This commercial development represents a positive step towards expanding VivaGel® BV sales, with Starpharma now free to engage with healthcare companies that have a strong consumer franchise and have already expressed interest in VivaGel® BV.”